Evidence map›Paper›PMID 32218621›Full record

ArticleThe Ulster medical journal2020

Natural history of a fibrous cephalic plaque and sustained eight decade follow-up in an 80 year old with tuberous sclerosis complex type 2.

Claire W Kirk, Deirdre E Donnelly, Rachel Hardy, Charles W Shepherd, Patrick J Morrison

Open access · greenAbstract readCase Reports
In one paragraph

Article in The Ulster medical journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Claire W KirkDepartment of Genetic Medicine, Belfast Health and Social Care Trust, Belfast BT9 7AB, UK.
Deirdre E DonnellyDepartment of Genetic Medicine, Belfast Health and Social Care Trust, Belfast BT9 7AB, UK.
Rachel HardyDepartment of Genetic Medicine, Belfast Health and Social Care Trust, Belfast BT9 7AB, UK.
Charles W ShepherdDepartment of Genetic Medicine, Belfast Health and Social Care Trust, Belfast BT9 7AB, UK.
Patrick J MorrisonDepartment of Genetic Medicine, Belfast Health and Social Care Trust, Belfast BT9 7AB, UK.
Belfast Health and Social Care Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionFibrous cephalic plaques (FCP) are a characteristic manifestation of tuberous sclerosis complex (TSC) and occur in one third of cases. Their natural history and long term course is unknown, as is the outcome of long term follow-up of TSC cases in old age. PHENOTYPE AND

methodsWe describe an 80 year old with TSC due to a c.2784dupC TSC2 mutation, who was diagnosed in infancy with an FCP and was regularly followed up at the TSC clinic over 8 decades with regular epilepsy treatment and renal monitoring.

resultsRegular clinical photography and clinical records document the plaque at different ages. The FCP naturally resolved at 74 years. Facial angiofibromas also faded with time in the last decade. His epilepsy and renal abnormalities remained under control with careful surveillance and monitoring. DISCUSSION: Natural aging in the eighth decade causes progressive laxity of collagen and leads to natural resolution of FCPs. This novel finding with a unique 80 year follow up yields valuable insights into the aging changes within FCPs and facial angiofibromas as the pathways linking facial angiofibromas and FCP's through the TGF-β1 pathway are now being elucidated.

conclusionWe present a clinical odyssey showing the natural progression and history of FCPs in TSC and comment on the mechanistic pathways allowing potential interventions in this disfiguring condition. TSC cases can be successfully managed and complications - particularly in the brain and kidney, can be avoided over an entire lifetime. This is encouraging for long term prospects for patients with TSC.

Indexed as

Skin AgingAged, 80 and overAngiofibromaFacial DermatosesFacial NeoplasmsHumansLongitudinal StudiesMaleScalp DermatosesSkin NeoplasmsTuberous SclerosisFibrous cephalic plaquenatural historyTuberous Sclerosis

Identifiers

PMID32218621
PMCPMC7027183
OpenAlexW3023965620

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.